Dale Godfrey
Science Advisor
Cancer
Avaliaimmuno Therapies
New Zealand
Biography
P​rofessor of Microbiology and Immunology, University of Melbourne, Australia. Professor Godfrey​ is chair of the Avalia’s Scientific Advisory Board. He is a Professor at The University of Melbourne and an NHMRC Senior Principal Research Fellow. He is also a member of the executive committee (PastÂPresident) of the Australasian Society for Immunology (ASI). Godfrey has published over 170 papers and has worked in the field of T cell biology for over 25 years, with a focus on T cell development and NKT cell biology where he has pioneered many studies into NKT cell development, function and antigen recognition. In recent years, Godfrey has extended his studies of T cells to include Type 1 and Type 2 NKT cells, gammaÂdelta T cells, CD1a, CD1b and CD1c restricted T cells, and Mucosal Associated Invariant T (MAIT) cells.
Research Interest
Cancer